Literature DB >> 14982867

Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin.

Pauline L Lee1, Ernest Beutler, Sreenivas V Rao, James C Barton.   

Abstract

Juvenile hemochromatosis is an early-onset form of iron storage disease characterized by hypogonadotrophic hypogonadism and cardiomyopathy. Recently, the putative causative gene (LOC148738) encoding a protein designated hemojuvelin was cloned. The previously proposed designation of this gene as HFE2 is contrary to established convention, because it is not a member of the HFE family. We suggest that it be designated HJV. We sequenced this gene in members of 2 previously reported kinships that manifest typical juvenile hemochromatosis. In one kinship, 2 previously undescribed mutations of HJV were identified, c.238T>C (C80R) and c.302T>C (L101P). In the second kinship, 2 previously identified mutations, G320V and I222N, were found. These studies confirm that mutations in HJV cause juvenile hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982867     DOI: 10.1182/blood-2004-01-0072

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

Review 1.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

Review 2.  The role of repulsive guidance molecules in the embryonic and adult vertebrate central nervous system.

Authors:  Bernhard K Mueller; Toshihide Yamashita; Gregor Schaffar; Reinhold Mueller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

3.  New HJV mutation in a patient with hyperferritinemia and H63D homozygosity for the HFE gene.

Authors:  Carles de Diego; Sonsoles Opazo; Angel Sánchez-Castaño; Pedro Martínez-Castro
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

4.  SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent.

Authors:  James C Barton; Ronald T Acton; Pauline L Lee; Carol West
Journal:  Blood Cells Mol Dis       Date:  2007-05-09       Impact factor: 3.039

5.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.

Authors:  Jaroslav Truksa; Hongfan Peng; Pauline Lee; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

6.  Two middle-age-onset hemochromatosis patients with heterozygous mutations in the hemojuvelin gene in a Chinese family.

Authors:  Shufeng Li; Jun Xue; Baojun Chen; Qiwei Wang; Minke Shi; Xiaojing Xie; Liang Zhang
Journal:  Int J Hematol       Date:  2014-03-02       Impact factor: 2.490

7.  Clinical penetrance of C282Y homozygous HFE haemochromatosis.

Authors:  Enrico Rossi; Gary P Jeffrey
Journal:  Clin Biochem Rev       Date:  2004-08

Review 8.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

9.  Severe iron overload with a novel aminolevulinate synthase mutation and hepatitis C infection. A case report.

Authors:  Pauline Lee; Lawrence Rice; John J McCarthy; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2008-09-26       Impact factor: 3.039

10.  Non-HFE hemochromatosis.

Authors:  Paulo Caleb Júnior de Lima Santos; Carla Luana Dinardo; Rodolfo Delfini Cançado; Isolmar Tadeu Schettert; José Eduardo Krieger; Alexandre Costa Pereira
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.